Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 4.220
+0.120 (2.93%)
May 22, 2026, 11:20 AM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 118.99 million as of May 22, 2026. Its market cap has decreased by -77.39% in one year.
Market Cap
118.99M
Enterprise Value
451.58M
Revenue
287.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.22
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 118.99M, a decrease of -41.98%. That is a compound annual growth rate of -8.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 118.99M | -67.26% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 160.31M |
| Elicera Therapeutics AB | 145.85M |
| Alligator Bioscience AB | 132.84M |
| NextCell Pharma AB | 126.99M |
| Simris Group AB (PUBL) | 108.25M |
| IRLAB Therapeutics AB | 106.85M |
| OncoZenge AB | 102.27M |
| AcouSort AB | 102.01M |